• Marca Money
  • About Us
  • Calculators
  • Contact Us
  • Privacy Policy
MarcaMoney
  • Business
  • Banking & Finance
  • Brands
  • Startups
  • People Spotting
  • Media
  • Sports
  • Tech
MarcaMoneyMarcaMoney
Search
  • Business
    • Companies
    • Investment
    • Mergers & Acquisitions
    • People Spotting
    • Markets
  • Brands
    • Advertising
    • Agency
    • Marketing
    • PR
  • Startups
    • Funding
    • Unicorns
    • Fintech
    • Venture Capital
  • Industry
    • Auto
    • BFSI
    • Media
    • Hospitality
    • Healthcare
    • Real Estate
    • IT
    • Retail
  • Money
    • Mutual Funds
    • Personal Finance
    • Wealth Management
  • Tech
    • Apps
    • Gadgets
  • Sports
    • Sports Business
    • Sports Media
  • Gaming
  • Entertainment
  • Education
  • About Us
  • Contact Us
  • Privacy Policy
Follow US
© MarcaMoney. All Rights Reserved.
Home > Startups > Venture Capital > HealthKois $300 million healthcare transformation fund

HealthKois $300 million healthcare transformation fund

Over the next four years, the firm will invest between $7 million to $25 million per company in early growth-stage businesses operating across healthtech, life sciences, medtech, healthcare delivery and climate health.

Abhinav Kumar Singh
Last updated: June 6, 2025 3:11 PM
By Abhinav Kumar Singh
HealthKois $300 million healthcare transformation fund
HealthKois $300 million healthcare transformation fund
SHARE

HealthKois, a healthcare transformation investment fund, has launched with a target corpus of $300 million, and an additional green shoe option of $100 million.

The fund has been established by the key leadership team behind HealthQuad, Charles Janssen (Managing Partner), Ajay Mahipal (Partner) and Dr Pinak Shrikhande (Partner).

As a successor fund to HealthQuad, HealthKois will accelerate India’s healthcare evolution by investing in technology-enabled, scalable, and high-impact enterprises. The fund is focused on supporting companies that offer robust operational scalability, demonstrable clinical outcomes, and sustainable infrastructure solutions.

More Read
Equirus InnovateX Fund announces final close of B2B tech fund at ₹166 crore
Equirus InnovateX Fund announces final close of B2B tech fund at ₹166 crore
Bertelsmann Investments launches Bertelsmann Next India, acquires 80% stake in LetsTransport
Bertelsmann Investments launches Bertelsmann Next India, acquires 80% stake in LetsTransport
Mirae Asset Venture Investments appoints Puneet Kumar as CEO
Mirae Asset Venture Investments appoints Puneet Kumar as CEO

HealthKois aims to deliver top-tier risk-adjusted financial returns alongside measurable societal impact. Over the next four years, the firm will invest between $7 million to $25 million per company in early growth-stage businesses operating across healthtech, life sciences, medtech, healthcare delivery and climate health.

Backed by over a century of the combined expertise of the founders in clinical care, operations, and healthcare investing, HealthKois adopts a founder-first, hands-on approach. Leveraging a global network across Asia and Europe, the firm actively supports its portfolio with strategic guidance, go-to-market planning, organizational design, and governance. Beyond capital, HealthKois serves as a long-term partner, driving growth, enabling market expansion, and fostering value creation at every stage.

Charles Janssen, Managing Partner, HealthKois, said, “HealthKois will back technology-led and innovative healthcare companies that address critical gaps in accessibility, affordability, and quality of care. Our goal is to transform care delivery by enabling early-growth ventures that bring real-world impact. With access to over 75 per cent proprietary deal flow, we’re well-positioned to leverage our deep networks and operational expertise to deliver both superior financial returns and societal outcomes.”

Ajay Mahipal, Partner, HealthKois, said, “HealthKois represents our deep belief that meaningful change in healthcare can only be achieved by scaling enterprises that blend purpose with performance. At HealthKois, we’re not just capital providers, we are long-term collaborators with founders, bringing strategic direction, global networks, and deep sector knowledge to help unlock their full potential. We invest in ventures that revolutionize healthcare delivery while also strengthening infrastructure resilience in India and other LMIC markets.”

Dr Pinak Shrikhande, Partner, HealthKois, said, “Our experience has taught us that true innovation in healthcare is born out of empathy, evidence, and execution. We look for companies that go beyond intent to deliver real clinical and operational impact. Transformation doesn’t happen in silos, it requires a blend of clinical insight, practical know-how, and the conviction to back bold ideas. At HealthKois, we bring a hands-on, collaborative approach rooted in trust and deep sector expertise, enabling founders to build scalable, outcome-driven solutions that truly move the needle for patients and health systems alike.”

HealthKois builds upon the legacy of HealthQuad Funds I and II, which have successfully backed companies having touched over 90 million lives and serving 8.2 million patients annually. While HealthQuad Funds I and II will continue to operate under the existing framework, HealthKois marks a significant evolution in the mission to catalyse healthcare transformation in India and other emerging markets.

TAGGED:HealthKois

Latest News

Funding

ZeroMobIt raises ₹1.5 crore in pre-seed funding round

Funding

HireBound raises $2 million in seed funding led by Kalaari Capital

Funding

DATOMS raises ₹25 crore in Series A funding round led by Big Capital JSC

Sports Business

ISL 2025-26: Mumbai City FC announces Matix as Associate Partner

Sports Business

ISL 2025-26: Mumbai City FC signs Indian Super Gaming League as Official Back of Shirt Partner

Sports Business

Punjab Kings onboards CP PLUS as Title Sponsor for IPL 2026

Funding

Navikenz raises $7.5 million in seed funding round

Funding

Peptris raises ₹70 crore in Series A funding led by IAN Alpha Fund and Speciale Invest

Funding

Roopya raises ₹4 crore in seed funding led by Inflection Point Ventures

Funding

Beep raises $850K in pre-Series A funding round

You Might Also Like

Quadria Capital secures partial exit in NephroPlus IPO
Quadria Capital

Quadria Capital secures partial exit in NephroPlus IPO

Speciale Invest launches ₹1,400 crore Growth Fund II to back deep-tech startups
Speciale Invest

Speciale Invest launches ₹1,400 crore Growth Fund II to back deep-tech startups

ISFB launches ₹25 crore venture fund for student founders
Imarticus School of Finance and Business

ISFB launches ₹25 crore venture fund for student founders

BYT Capital launches ₹180 crore maiden fund
BYT Capital

BYT Capital launches ₹180 crore maiden fund

Centre Court Capital closes maiden fund at ₹410 crore
Centre Court Capital

Centre Court Capital closes maiden fund at ₹410 crore

IAN Group announces final close of IAN Alpha Fund with $100 million
IAN Alpha Fund

IAN Group announces final close of IAN Alpha Fund with $100 million

MarcaMoney

Business News

  • Companies
  • Economy
  • Global Business
  • Money
  • Personal Finance
  • Startups
  • Brands
  • Advertising
  • Marketing
  • PR

Industry News

  • Auto
  • Banking & Finance
  • Healthcare
  • Hospitality
  • IT
  • Media
  • Real Estate
  • Retail

Other News

  • Art & Culture
  • Education
  • Elections
  • Entertainment
  • Lifestyle
  • Sports
  • Tech

Calculator

  • SIP Calculator
  • Step Up SIP Calculator
  • Lumpsum Calculator
  • SBI SIP Calculator
  • HDFC SIP Calculator

© 2025 MarcaMoney.

  • About Us
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Google News Sitemap